1. Edoxaban

   • A. John Camm
   • Henri Bounameaux

   Leading Article 24 September 2012 Pages: 1503 - 1526

   

2. Biosimilars of Biological Drug Therapies

   • George Dranitsaris
   • Eitan Amir
   • Kristine Dorward

   Current Opinion 24 September 2012 Pages: 1527 - 1536

   

3. Acute Myeloid Leukaemia

   • Luis Villela
   • Javier Bolaños-Meade

   Therapy in Practice 24 September 2012 Pages: 1537 - 1550

   

4. Management of Recurrent Head and Neck Cancer

   • Bruce E. Brockstein

   Therapy in Practice 24 September 2012 Pages: 1551 - 1559

   

5. Once-Versus Twice-Daily Tacrolimus

   • Katherine A. Barraclough
   • Nicole M. Isbel
   • Christine E. Staatz

   Review Article 24 September 2012 Pages: 1561 - 1577

   

6. Erratum to: Trastuzumab: a review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer

   • KP Garnock-Jones
   • GM Keating
   • LJ Scott

   Erratum 24 September 2012 Pages: 1578 - 1578

7. Nilotinib

   • Karly P. Garnock-Jones

   Adis Drug Profile 24 September 2012 Pages: 1579 - 1590

   

8. Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)

   • Natalie J. Carter
   • Monique P. Curran

   Adis Drug Evaluation 24 September 2012 Pages: 1591 - 1622

   

9. Plerixafor

   • Gillian M. Keating

   Adis Drug Evaluation 24 September 2012 Pages: 1623 - 1647